title: Allogeneic Hematopoietic Stem-Cell Transplantation in Myelofibrosis: Key Messages for Clinical Practice in the Era of Janus Kinase 1/2 Inhibitors.
authors.affiliation: Thammasat University, Bangkok, Thailand, and The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Piyanuch
authors.initials: P
authors.lastname: Kongtim
authors.affiliation: Thammasat University, Bangkok, Thailand, and The University of Texas MD Anderson Cancer Center, Houston, TX upopat@mdanderson.org.
authors.forename: Uday
authors.initials: U
authors.lastname: Popat
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053613:Janus Kinase 1; D055728:Primary Myelofibrosis; D047428:Protein Kinase Inhibitors; D019172:Transplantation Conditioning
chemical_list: D047428:Protein Kinase Inhibitors; D053613:Janus Kinase 1